Patients with spontaneous remission of high-risk MDS and AML show persistent preleukemic clonal hematopoiesis.
Victoria V GrunwaldMarcus HentrichXaver SchielAnnika DufourStephanie SchneiderMichaela NeusserMarion SubkleweMichael FieglWolfgang HiddemannKarsten SpiekermannMaja Rothenberg-ThurleyKlaus H MetzelerPublished in: Blood advances (2020)